These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 22920753)
1. Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression. Liu J; Yang L; Zhang J; Zhang J; Chen Y; Li K; Li Y; Li Y; Yao L; Guo G BMC Cancer; 2012 Aug; 12():370. PubMed ID: 22920753 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes. Yang F; Guo L; Cao Y; Li S; Li J; Liu M Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819 [TBL] [Abstract][Full Text] [Related]
3. NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis. Kang F; Wang Y; Luo Y; Zhang Y J Ovarian Res; 2020 Apr; 13(1):48. PubMed ID: 32345304 [TBL] [Abstract][Full Text] [Related]
4. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891 [TBL] [Abstract][Full Text] [Related]
5. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells. Mehta H; Ambele MA; Mokgautsi N; Moela P Cells; 2024 Apr; 13(8):. PubMed ID: 38667315 [TBL] [Abstract][Full Text] [Related]
6. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2. Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050 [TBL] [Abstract][Full Text] [Related]
7. [MiR-503 sensitizes human hepatocellular carcinoma cells to cisplatin by targeting bcl-2]. Yang X; Yin J; Xiang Q; Xie H; Yu J; Gan R; Lei X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):605-610. PubMed ID: 28690214 [TBL] [Abstract][Full Text] [Related]
8. Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin. Yu L; Wang Z J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):625-30. PubMed ID: 19821098 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin. Li N; Zhang W Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28246354 [TBL] [Abstract][Full Text] [Related]
10. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs]. Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Zhang X; Huang L; Zhao Y; Tan W Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606 [TBL] [Abstract][Full Text] [Related]
12. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112 [TBL] [Abstract][Full Text] [Related]
13. miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Liu L; Yu X; Guo X; Tian Z; Su M; Long Y; Huang C; Zhou F; Liu M; Wu X; Wang X Mol Med Rep; 2012 Mar; 5(3):753-60. PubMed ID: 22160209 [TBL] [Abstract][Full Text] [Related]
14. [Influence of survivin gene repression by RNA interference on the radiosensitivity and chemosensitivity to cisplatin of cervical cancer cell HeLa]. Song H; Xin XY; Xiao F; Wang DT; Han X; Guo HL Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):554-8. PubMed ID: 17083843 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer. Ye Z; Hao R; Cai Y; Wang X; Huang G Tumour Biol; 2016 Apr; 37(4):4509-15. PubMed ID: 26503209 [TBL] [Abstract][Full Text] [Related]
16. Chen C; Zhou Y; Ding P; He L Genet Test Mol Biomarkers; 2021 Aug; 25(8):540-545. PubMed ID: 34406846 [No Abstract] [Full Text] [Related]
17. Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance. Leisching G; Loos B; Botha M; Engelbrecht AM J Transl Med; 2015 Oct; 13():328. PubMed ID: 26474854 [TBL] [Abstract][Full Text] [Related]
18. miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1. Li X; Li Y; Han Y; Dong B; Liu D; Che L; Liu Y; Wang Y Cancer Biother Radiopharm; 2020 Jun; 35(5):338-344. PubMed ID: 32379984 [No Abstract] [Full Text] [Related]
19. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling. Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452 [TBL] [Abstract][Full Text] [Related]
20. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]